Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Yamazaki

Showing results (71-80 of 252) with videos related to

Pageof 26
Sort By:
Annals of Gastroenterological Surgery|July 3, 2026
Management Strategies for Disappearing Colorectal Liver Metastases After Systemic Chemotherapy: Long-Term Outcomes and Preoperative Prediction of 'True Complete Response'Taihei Soma, Ryo Ashida, Takeshi Kawakami, et al.
Radiation Medicine|March 25, 2006
Postmortem magnetic resonance imaging (PMMRI) demonstration of reversible injury phase myocardium in a case of sudden death from acute coronary plaque changeSeiji Shiotani, Kentaro Yamazaki, Kazunori Kikuchi, et al.
Cancer Science|August 13, 2018
Phase I dose-escalation trial of Sym004, an anti-EGFR antibody mixture, in Japanese patients with advanced solid tumorsTakashi Kojima, Kentaro Yamazaki, Ken Kato, et al.
Anticancer Research|March 10, 2015
Safety and efficacy of adjuvant therapy with oxaliplatin, leucovorin and 5-fluorouracil after mesorectal excision with lateral pelvic lymph node dissection for stage iii lower rectal cancerSatoru Iwasa, Hiroaki Souda, Kentaro Yamazaki, et al.
Cancer Science|July 16, 2020
Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, 4th editionHiromichi Ebi, Hideaki Bando, Hiroya Taniguchi, et al.
Japanese Journal of Clinical Oncology|March 26, 2009
Activity of S-1 in advanced or recurrent gastric cancer patients after failure of prior chemotherapy, including irinotecan + cisplatin or fluorouracil (except S-1)Akira Ono, Narikazu Boku, Yusuke Onozawa, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 21, 2019
Adherence to a topical moisturizing preparation for regorafenib-related hand-foot skin reactionJunya Sato, Hiroshi Ishikawa, Satoshi Hamauchi, et al.
Japanese Journal of Clinical Oncology|November 8, 2008
Irinotecan plus cisplatin therapy and S-1 plus cisplatin therapy for advanced or recurrent gastric cancer in a single institutionKoji Nakashima, Shuichi Hironaka, Narikazu Boku, et al.
Japanese Journal of Clinical Oncology|August 28, 2007
Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in JapanTakayuki Yoshino, Narikazu Boku, Yusuke Onozawa, et al.
Investigational New Drugs|November 27, 2012
A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancerTakayuki Yoshino, Kentaro Yamazaki, Kensei Yamaguchi, et al.
Pageof 26

Showing results (71-80 of 252) with videos related to

Sort By:
Pageof 26
Annals of Gastroenterological Surgery|July 3, 2026
Management Strategies for Disappearing Colorectal Liver Metastases After Systemic Chemotherapy: Long-Term Outcomes and Preoperative Prediction of 'True Complete Response'Taihei Soma, Ryo Ashida, Takeshi Kawakami, et al.
Radiation Medicine|March 25, 2006
Postmortem magnetic resonance imaging (PMMRI) demonstration of reversible injury phase myocardium in a case of sudden death from acute coronary plaque changeSeiji Shiotani, Kentaro Yamazaki, Kazunori Kikuchi, et al.
Cancer Science|August 13, 2018
Phase I dose-escalation trial of Sym004, an anti-EGFR antibody mixture, in Japanese patients with advanced solid tumorsTakashi Kojima, Kentaro Yamazaki, Ken Kato, et al.
Anticancer Research|March 10, 2015
Safety and efficacy of adjuvant therapy with oxaliplatin, leucovorin and 5-fluorouracil after mesorectal excision with lateral pelvic lymph node dissection for stage iii lower rectal cancerSatoru Iwasa, Hiroaki Souda, Kentaro Yamazaki, et al.
Cancer Science|July 16, 2020
Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, 4th editionHiromichi Ebi, Hideaki Bando, Hiroya Taniguchi, et al.
Japanese Journal of Clinical Oncology|March 26, 2009
Activity of S-1 in advanced or recurrent gastric cancer patients after failure of prior chemotherapy, including irinotecan + cisplatin or fluorouracil (except S-1)Akira Ono, Narikazu Boku, Yusuke Onozawa, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 21, 2019
Adherence to a topical moisturizing preparation for regorafenib-related hand-foot skin reactionJunya Sato, Hiroshi Ishikawa, Satoshi Hamauchi, et al.
Japanese Journal of Clinical Oncology|November 8, 2008
Irinotecan plus cisplatin therapy and S-1 plus cisplatin therapy for advanced or recurrent gastric cancer in a single institutionKoji Nakashima, Shuichi Hironaka, Narikazu Boku, et al.
Japanese Journal of Clinical Oncology|August 28, 2007
Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in JapanTakayuki Yoshino, Narikazu Boku, Yusuke Onozawa, et al.
Investigational New Drugs|November 27, 2012
A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancerTakayuki Yoshino, Kentaro Yamazaki, Kensei Yamaguchi, et al.
Pageof 26